Rongjian Su
- Molecular Biology
- Cell Biology top 10%
- Oncology
- Biomaterials top 10%
- Cancer Research
- Topics
- Cancer-related gene regulation (6 papers)Nanoparticle-Based Drug Delivery (5 papers)Cancer Mechanisms and Therapy (4 papers)
- Journals
- Scientific ReportsInternational Journal of PharmaceuticsThe International Journal of Biochemistry & Cell Biology
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Rongjian Su
26 papers receiving 653 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 410
- Cell Biology 146
- Oncology 125
- Biomaterials 101
- Cancer Research 101
Countries citing papers authored by Rongjian Su
This map shows the geographic impact of Rongjian Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongjian Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongjian Su more than expected).
Fields of papers citing papers by Rongjian Su
This network shows the impact of papers produced by Rongjian Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongjian Su. The network helps show where Rongjian Su may publish in the future.
Co-authorship network of co-authors of Rongjian Su
This figure shows the co-authorship network connecting the top 25 collaborators of Rongjian Su. A scholar is included among the top collaborators of Rongjian Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongjian Su. Rongjian Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 18 | |
| 6 | 27 | |
| 7 | 40 | |
| 8 | 4 | |
| 9 | 33 | |
| 10 | 5 | |
| 11 | 45 | |
| 12 | 23 | |
| 13 | 62 | |
| 14 | 28 | |
| 15 | 50 | |
| 16 | 15 | |
| 17 | 15 | |
| 18 | 39 | |
| 19 | 85 | |
| 20 | 11 |
About Rongjian Su
Rongjian Su is a scholar working on Biomaterials, Cell Biology and Pathology and Forensic Medicine, having authored 27 papers that have together received 654 indexed citations. Recurring topics across this work include Cancer-related gene regulation (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cell Biology (146 citations), Biomaterials (101 citations) and Cancer Research (101 citations). Rongjian Su has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Hongdan Li, Liang Zhao, Chang Su, Hua‐chuan Zheng, Liwei Liu, Huijuan Song, Shuang Zhao, Xuefeng Yang, Song Zhao and Hongzhi Sun. Their work appears in journals such as Scientific Reports, International Journal of Pharmaceutics and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.